We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




2011 BIO International Convention Sets Attendance Records

By LabMedica International staff writers
Posted on 06 Jul 2011
The 2011 BIO International Convention, the largest global event for the biotechnology industry, set new records in partnering meetings, and increased international attendance and participation. More...
The convention program included panel sessions on the latest scientific, policy and business opportunities and challenges facing the industry. The conference, hosted by the Biotechnology Industry Organization (BIO; Washington DC, USA) in Washington DC (USA), drew 15,626 industry leaders from the US and other 65 countries.

“The 2011 BIO International Convention was an enormous success, bringing together leaders from industry, government, and academia who are working to solve some of the sector’s biggest challenges,” said President and CEO of BIO Jim Greenwood. “Bringing the global biotech industry to Washington DC, [USA], gave us the critical opportunity to showcase to key policymakers our industry’s promise to offer real solutions to the most pressing global challenges such as curing disease, reducing health care costs, combating hunger, discovering alternative forms of energy and creating high-wage jobs. We continue to advocate for a policy and regulatory environment that will support innovation and inspire industry growth.”

Keynote sessions included the former UK Prime Minister Tony Blair, US Senator John Barrasso, former US Senator Tom Daschle, Vermont Governor Howard Dean, and Republican political strategist Karl Rove. The Convention program featured more than 125 sessions across 15 tracks, including Global Innovations and Markets, Health Policy and Reimbursement, Biosecurity, Business Development, Food and Agriculture, and Biofuels, and Biobased Chemicals.

The BIO Business Forum hosted a record-breaking 21,183 partnering meetings between 2,410 companies and featured 157 company presentations. According to the BIO Business Forum Partnering Report there is high demand for Phase I assets as well as Central Nervous System (CNS), immunology, and metabolic therapeutic areas compared to 2010. In addition, the 2010 top-three-highest interest therapeutic areas in including cardiovascular, oncology, and respiratory categories are now all in the bottom half of 2011's top 10 areas.

The 2012 BIO International Convention will take place during June 18-21, 2012, at the Boston Convention and Exhibition Center in Boston (MA, USA).

Related Links:
BIO International Convention
Biotechnology Industry Association



New
Gold Member
Hematology Analyzer
Medonic M32B
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Sperm Quality Analyis Kit
QwikCheck Beads Precision and Linearity Kit
New
Automated Biochemical Analyzer
iBC 900
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: The microfluidic device for passive separation of platelet-rich plasma from whole blood (Photo courtesy of University of the Basque Country)

Portable and Disposable Device Obtains Platelet-Rich Plasma Without Complex Equipment

Platelet-rich plasma (PRP) plays a crucial role in regenerative medicine due to its ability to accelerate healing and repair tissue. However, obtaining PRP traditionally requires expensive centrifugation... Read more

Immunology

view channel
Image: Prof. Nicholas Schwab has found a biomarker that can predict treatment outcome of glatirameracetate in MS patients (Photo courtesy of Uni MS - M. Ibrahim)

Simple Genetic Testing Could Predict Treatment Success in Multiple Sclerosis Patients

Multiple sclerosis (MS) patients starting therapy often face a choice between interferon beta and glatiramer acetate, two equally established and well-tolerated first-line treatments. Until now, the decision... Read more

Microbiology

view channel
Image: New diagnostics could predict a woman’s risk of a common sexually transmitted infection (Photo courtesy of 123RF)

New Markers Could Predict Risk of Severe Chlamydia Infection

Chlamydia trachomatis is a common sexually transmitted infection that can cause pelvic inflammatory disease, infertility, and other reproductive complications when it spreads to the upper genital tract.... Read more

Pathology

view channel
Image: (A) Normal skin and (B) possible pathology in ALS skin (Photo courtesy of Biomolecules and Biomedicine (2025) DOI: 10.17305/bb.2025.12100)

Skin-Based Biomarkers to Enable Early Diagnosis of Amyotrophic Lateral Sclerosis

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease that damages motor neurons in the brain and spinal cord, causing muscle weakness, paralysis, and death within three to five... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.